Laurence Salin

590 total citations
13 papers, 398 citations indexed

About

Laurence Salin is a scholar working on Neurology, Cognitive Neuroscience and Rheumatology. According to data from OpenAlex, Laurence Salin has authored 13 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 3 papers in Cognitive Neuroscience and 3 papers in Rheumatology. Recurrent topics in Laurence Salin's work include Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Parkinson's Disease and Spinal Disorders (4 papers). Laurence Salin is often cited by papers focused on Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Parkinson's Disease and Spinal Disorders (4 papers). Laurence Salin collaborates with scholars based in France, United States and Austria. Laurence Salin's co-authors include Robert A. Hauser, Nolwenn Juhel, Olivier Rascol, Paolo Barone, Werner Poewe, Anthony H.V. Schapira, Yoshikuni Mizuno, André Kahan, Michael Busse and Patrick Durez and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Movement Disorders.

In The Last Decade

Laurence Salin

12 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Salin France 7 275 66 61 55 47 13 398
P Lamberti Italy 8 275 1.0× 44 0.7× 68 1.1× 18 0.3× 16 0.3× 13 371
Luca Ausili Cefaro Italy 7 116 0.4× 53 0.8× 22 0.4× 205 3.7× 33 0.7× 10 416
C. D’Avino Italy 10 193 0.7× 75 1.1× 50 0.8× 20 0.4× 10 0.2× 12 333
Nalina Dronamraju United States 9 148 0.5× 91 1.4× 17 0.3× 27 0.5× 31 0.7× 15 398
Paola Ferrigno Italy 8 135 0.5× 19 0.3× 25 0.4× 13 0.2× 27 0.6× 10 284
Pingping Ning China 12 179 0.7× 66 1.0× 20 0.3× 12 0.2× 28 0.6× 29 318
C. Coronado Erdmann Germany 9 210 0.8× 40 0.6× 16 0.3× 8 0.1× 17 0.4× 12 339
Younghee Yim South Korea 9 65 0.2× 93 1.4× 13 0.2× 28 0.5× 27 0.6× 30 361
Edwin Dunteman United States 7 108 0.4× 27 0.4× 16 0.3× 62 1.1× 14 0.3× 13 298

Countries citing papers authored by Laurence Salin

Since Specialization
Citations

This map shows the geographic impact of Laurence Salin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Salin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Salin more than expected).

Fields of papers citing papers by Laurence Salin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Salin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Salin. The network helps show where Laurence Salin may publish in the future.

Co-authorship network of co-authors of Laurence Salin

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Salin. A scholar is included among the top collaborators of Laurence Salin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Salin. Laurence Salin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Isaacson, Stuart, Tanya Simuni, Laurence Salin, et al.. (2022). Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Results from the ongoing BeyoND study (P10-11.006). Neurology. 98(18_supplement). 1 indexed citations
3.
Poewe, Werner, Olivier Rascol, Paolo Barone, et al.. (2011). Extended-release pramipexole in early Parkinson disease. Neurology. 77(8). 759–766. 64 indexed citations
4.
Schapira, Anthony H.V., Paolo Barone, Robert A. Hauser, et al.. (2011). Extended-release pramipexole in advanced Parkinson disease. Neurology. 77(8). 767–774. 82 indexed citations
5.
Schapira, Anthony H.V., Paolo Barone, Y Mizuno, et al.. (2010). Sustained efficacy and tolerability of pramipexole extended-release as adjunctive treatment in advanced Parkinson's disease. UCL Discovery (University College London). 1 indexed citations
6.
Hauser, Robert A., Anthony H.V. Schapira, Olivier Rascol, et al.. (2010). Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. Movement Disorders. 25(15). 2542–2549. 80 indexed citations
7.
Rascol, Olivier, Paolo Barone, Robert A. Hauser, et al.. (2010). Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease. Movement Disorders. 25(14). 2326–2332. 30 indexed citations
8.
Rascol, Olivier, Paolo Barone, R. Hauser, et al.. (2009). P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage. Parkinsonism & Related Disorders. 15. S131–S132. 1 indexed citations
9.
Schapira, Anthony H.V., Paolo Barone, R. Hauser, et al.. (2009). P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease. Parkinsonism & Related Disorders. 15. S133–S133. 1 indexed citations
10.
Díaz‐González, Federico, W. Bensen, Jacques P. Brown, et al.. (2006). Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(5). 628–632. 38 indexed citations
11.
Hauser, Robert A., et al.. (2006). Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease. Movement Disorders. 22(3). 359–365. 38 indexed citations
12.
Kahan, André, et al.. (2003). Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine. 70(4). 276–281. 59 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Lamberti Breakdown of academic impact, for papers by Luca Ausili Cefaro Breakdown of academic impact, for papers by C. D’Avino Breakdown of academic impact, for papers by Nalina Dronamraju Breakdown of academic impact, for papers by Paola Ferrigno Breakdown of academic impact, for papers by Pingping Ning Breakdown of academic impact, for papers by C. Coronado Erdmann Breakdown of academic impact, for papers by Younghee Yim Breakdown of academic impact, for papers by Edwin Dunteman
Rankless by CCL
2026